<DOC>
	<DOCNO>NCT01184508</DOCNO>
	<brief_summary>The primary objective study measure change frequency migraine attack per 28 day migraine patient treat orally LY2300559 12 week .</brief_summary>
	<brief_title>A Study Migraine Prevention</brief_title>
	<detailed_description />
	<mesh_term>Headache</mesh_term>
	<mesh_term>Migraine Disorders</mesh_term>
	<criteria>Are migraine patient migraine onset 50 year age Present diagnosis least 1 year migraine attack define International Headache Society ( IHS ) guideline Have frequency 4 14 migraine attack , without aura , per month ( 14 headache day per month , migraine nonmigraine ) least last 6 month Female patient childbearing potential must test negative pregnancy time enrollment agree use reliable method birth control study Are currently enrol , discontinue within previous 6 month migraine clinical trial involve investigational drug device offlabel use drug device Are currently enrol , discontinue within previous 30 day Screening nonmigraine clinical trial involve investigational drug device offlabel use drug device , concurrently enrol type medical research judge scientifically medically compatible study Have previously complete withdrawn study study investigate LY2300559 Have know allergy LY2300559 related compound ( montelukast ) Are treatment medication procedure prevention migraine , take medication exclude protocol Have history alcohol drug abuse/dependence within past 3 month screen currently use alcohol , drug abuse ( include opioids , barbiturate , marijuana ) , prescribed overthecounter medication manner investigator considers indicative abuse/dependence Screen positive drug abuse Patients medication overuse headache per IHS definition Have body mass index ( BMI ) less 18.5 great equal 35.0 Have history presence cardiovascular , respiratory , hepatic , renal , gastrointestinal , endocrine , hematological neurological disorder capable significantly alter absorption , metabolism , elimination drug , constitute risk take study medication interfere interpretation data Show evidence serious active neuropsychiatric disease include , limited , bipolar disorder , schizophrenia , psychosis , cluster B personality disorder ( eg , borderline personality disorder , narcissistic personality disorder ) , obsessivecompulsive disorder , serious mood , anxiety , depression , substance/alcohol use disorder Have ever his/her lifetime attempt suicide , recent suicidal ideation within last 3 month , significant risk commit suicide , judge investigator Show evidence history neurological disease cerebral vascular accident , pseudotumor cerebri , multiple sclerosis , transient ischemic attack , syncopal episode , encephalitis , meningitis Have history seizure febrile Female patient pregnant breastfeeding . Females childbearing potential use clinically acceptable method birth control ( eg , oral contraceptive , abstinence ) Are unwilling unable comply use data collection device directly record patient data Are otherwise unable comply requirement study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>October 2012</verification_date>
	<keyword>classic aura</keyword>
	<keyword>common without aura</keyword>
	<keyword>migraine</keyword>
	<keyword>headache</keyword>
</DOC>